Altınay, S. Et Al. 2023. Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind. Anti-Cancer Agents in Medicinal Chemistry , vol.23, no.3 , 298-305.

Altınay, S., Kural, A., Özmen, A., Tural, D., & TUTAR, Y., (2023). Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind. Anti-Cancer Agents in Medicinal Chemistry , vol.23, no.3, 298-305.

Altınay, Serdar Et Al. "Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind," Anti-Cancer Agents in Medicinal Chemistry , vol.23, no.3, 298-305, 2023

Altınay, Serdar Et Al. "Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind." Anti-Cancer Agents in Medicinal Chemistry , vol.23, no.3, pp.298-305, 2023

Altınay, S. Et Al. (2023) . "Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind." Anti-Cancer Agents in Medicinal Chemistry , vol.23, no.3, pp.298-305.

@article{article, author={Serdar Altınay Et Al. }, title={Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind}, journal={Anti-Cancer Agents in Medicinal Chemistry}, year=2023, pages={298-305} }